174 related articles for article (PubMed ID: 30674061)
21. JAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic views.
Gangat N; Szuber N; Pardanani A; Tefferi A
Leukemia; 2021 Aug; 35(8):2166-2181. PubMed ID: 34021251
[TBL] [Abstract][Full Text] [Related]
22. Molecular study of congenital erythrocytosis in 70 unrelated patients revealed a potential causal mutation in less than half of the cases (Where is/are the missing gene(s)?).
Bento C; Almeida H; Maia TM; Relvas L; Oliveira AC; Rossi C; Girodon F; Fernandez-Lago C; Aguado-Diaz A; Fraga C; Costa RM; Araújo AL; Silva J; Vitória H; Miguel N; Silveira MP; Martin-Nuñez G; Ribeiro ML
Eur J Haematol; 2013 Oct; 91(4):361-8. PubMed ID: 23859443
[TBL] [Abstract][Full Text] [Related]
23. WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.
Michiels JJ; De Raeve H; Hebeda K; Lam KH; Berneman Z; Schroyens W; Schwarz J
Leuk Res; 2007 Aug; 31(8):1031-8. PubMed ID: 17367853
[TBL] [Abstract][Full Text] [Related]
24. The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.
Thiele J; Kvasnicka HM; Zankovich R; Diehl V
Haematologica; 2001 Apr; 86(4):368-74. PubMed ID: 11325641
[TBL] [Abstract][Full Text] [Related]
25. The clinical and laboratory evaluation of the patient with erythrocytosis.
Lee G; Arcasoy MO
Eur J Intern Med; 2015 Jun; 26(5):297-302. PubMed ID: 25837692
[TBL] [Abstract][Full Text] [Related]
26. Radioimmunoassay of immunoreactive erythropoietin as a clinical tool for the classification of polycythaemias.
Najean Y; Schlageter MH; Toubert ME; Podgorniak MP
Nouv Rev Fr Hematol (1978); 1990; 32(4):237-40. PubMed ID: 2290709
[TBL] [Abstract][Full Text] [Related]
27. Secondary Hypertension, Erythrocytosis, and Unilateral Renal Cystic Disease in a Submariner: A Case Report.
Forbes AS; Yeo FE
J Spec Oper Med; 2016; 16(4):1-5. PubMed ID: 28088811
[TBL] [Abstract][Full Text] [Related]
28. The role of serum erythropoietin level and JAK2 V617F allele burden in the diagnosis of polycythaemia vera.
Ancochea A; Alvarez-Larrán A; Morales-Indiano C; García-Pallarols F; Martínez-Avilés L; Angona A; Senín A; Bellosillo B; Besses C
Br J Haematol; 2014 Nov; 167(3):411-7. PubMed ID: 25040297
[TBL] [Abstract][Full Text] [Related]
29. Annual Clinical Updates in Hematological Malignancies: a continuing medical education series: polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk-stratification, and management.
Tefferi A
Am J Hematol; 2011 Mar; 86(3):292-301. PubMed ID: 21351120
[TBL] [Abstract][Full Text] [Related]
30. Elevated serum erythropoietin in a patient with polycythaemia vera presenting with Budd-Chiari syndrome.
Jones C; Levy Y; Tong AW
BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25452296
[TBL] [Abstract][Full Text] [Related]
31. The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia.
Bellucci S; Michiels JJ
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):381-98. PubMed ID: 16810614
[TBL] [Abstract][Full Text] [Related]
32. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
[TBL] [Abstract][Full Text] [Related]
33. Determination of serum immunoreactive erythropoietin in the investigation of erythrocytosis.
Cotes PM; Doré CJ; Yin JA; Lewis SM; Messinezy M; Pearson TC; Reid C
N Engl J Med; 1986 Jul; 315(5):283-7. PubMed ID: 3724821
[TBL] [Abstract][Full Text] [Related]
34. "Benign erythrocytosis" and other familial and congenital polycythemias.
Prchal JT; Sokol L
Eur J Haematol; 1996 Oct; 57(4):263-8. PubMed ID: 8982288
[TBL] [Abstract][Full Text] [Related]
35. Erythrocytosis in patients with renal failure on hemodialysis: study of underlying mechanism by in vitro erythroid culture assay.
Shih LY; Leu ML
Exp Hematol; 1993 Aug; 21(9):1239-43. PubMed ID: 8330648
[TBL] [Abstract][Full Text] [Related]
36. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.
Tefferi A
Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582
[TBL] [Abstract][Full Text] [Related]
37. Elevated serum erythropoietin levels in patients with Budd-Chiari syndrome secondary to polycythemia vera: clinical implications for the role of JAK2 mutation analysis.
Thurmes PJ; Steensma DP
Eur J Haematol; 2006 Jul; 77(1):57-60. PubMed ID: 16827884
[TBL] [Abstract][Full Text] [Related]
38. Erythropoietin receptor and hematological disease.
McMullin MF; Percy MJ
Am J Hematol; 1999 Jan; 60(1):55-60. PubMed ID: 9883806
[TBL] [Abstract][Full Text] [Related]
39. Erythropoiesis in familial erythrocytosis.
Greenberg BR; Golde DW
N Engl J Med; 1977 May; 296(19):1080-4. PubMed ID: 850518
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of a one step sandwich enzymeimmunoassay for serum erythropoietin--serum erythropoietin values in polycythemia vera and related hematological disorders].
Sawabe Y; Iida S; Tabata Y; Yonemitsu H
Rinsho Byori; 1993 Jan; 41(1):75-82. PubMed ID: 8355412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
